Author:
Tan Shijie,Zhao Zhe,Qiao Yingnan,Zhang Bin,Zhang Tong,Zhang Mengli,Qi Jindan,Wang Xiaohua,Meng Mei,Zhou Quansheng
Subject
Pharmacology,Biochemistry
Reference78 articles.
1. Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity;Kokolus;Oncoimmunology,2019
2. Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma;Robert;New Engl. J. Med.,2019
3. Immunotherapy of melanoma: facts and hopes;Weiss;Clin. Cancer Res.,2019
4. Anti-PD-1 and novel combinations in the treatment of melanoma-an update;Gellrich;J. Clin. Med.,2020
5. Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: analysis from phase 2 and 3 clinical trials. European journal of cancer (Oxford;Hauschild;England,1990
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献